Brian Traquair, president of SunGard's capital-markets business, offers his view of how Basel III and changes in the over-the-counter derivatives market are taking shape. "In terms of ratios, the hit on capital is going to be immense. ... If you combine that with the likely initial margin for the OTC derivatives clearing space, the combination of those two things is just a huge squeeze play," he said.
Published in Brief: